This is a preview of subscription content, log in via an institution to check access.
Notes
New England Comparative Effectiveness Public Advisory Council
Reference
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Report Finds Extended-Release Treatments for Opioid Use Disorder Provide Only Marginal Benefits Over Generic Alternatives, at Significantly Higher Prices Internet Document : 25 Oct 2018. Available from: URL: https://icer-review.org/announcements/institute-for-clinical-and-economic-review-report-finds-extended-release-treatments-for-opioid-use-disorder-provide-only-marginal-benefits-over-generic-alternatives-at-significantly-higher-prices/
Rights and permissions
About this article
Cite this article
ICER finds extended-release opioid abuse therapies too costly. PharmacoEcon Outcomes News 815, 37 (2018). https://doi.org/10.1007/s40274-018-5418-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5418-9